NSG 508 Week 3 Discussion

Student Name

University of Phoenix

NSG/508 Theoretical Foundations of Advanced Nursing Practice

Prof. Name

Date

Mild Persistent Asthma in Adolescents: 

Mild persistent asthma in adolescents is most effectively managed with a daily low-dose inhaled corticosteroid (ICS) to reduce airway inflammation and a short-acting beta₂-agonist (SABA) for rapid symptom relief when needed. Successful treatment also includes regular follow-up, trigger avoidance, proper inhaler technique, and management of associated allergic rhinitis. With guideline-based care, most adolescents can achieve good symptom control, maintain normal lung function, and safely participate in sports and daily activities.

Understanding Mild Persistent Asthma in Adolescents

Asthma is a chronic inflammatory disease of the airways characterized by reversible airflow obstruction and bronchial hyperresponsiveness. In adolescents, mild persistent asthma commonly presents with symptoms occurring more than twice weekly but not daily, nighttime awakenings several times per month, and exercise-related respiratory symptoms.

A typical example is a 15-year-old adolescent experiencing:

• Shortness of breath during exercise

• Frequent dry cough

• Nighttime coughing several times each week

• Wheezing

• Allergic rhinitis symptoms such as nasal congestion, runny nose, or itchy eyes

A family history of asthma or seasonal allergies further increases the likelihood of allergic asthma.

Clinical Features and Assessment

Diagnosis is based on clinical history, physical examination, and objective assessment of lung function.

Common clinical findings include:

• Expiratory wheezing

• Increased respiratory rate during symptoms

• Pale, swollen nasal mucosa associated with allergic rhinitis

• Reduced peak expiratory flow (PEF) or abnormal spirometry

Healthcare providers should also assess:

• Symptom frequency

• Nighttime awakenings

• Activity limitations

• Rescue inhaler use

• Environmental and allergic triggers

• Family history of asthma or atopic disease

Goals of Asthma Treatment

The primary objectives of asthma management are to control symptoms, prevent exacerbations, and preserve long-term lung function while allowing adolescents to participate fully in school, sports, and daily activities.

Treatment goals include:

• Prevent daytime symptoms

• Eliminate nighttime coughing and sleep disruption

• Improve exercise tolerance

• Reduce airway inflammation

• Minimize rescue inhaler use

• Prevent emergency department visits and hospitalizations

• Maintain normal pulmonary function

• Control allergic rhinitis

• Reduce medication-related adverse effects

• Improve overall quality of life

First-Line Pharmacologic Treatment

Daily Low-Dose Inhaled Corticosteroids (ICS)

Current asthma guidelines recommend a low-dose inhaled corticosteroid (ICS) as the preferred controller medication for adolescents with mild persistent asthma.

ICS therapy works by:

• Reducing chronic airway inflammation

• Decreasing airway hyperresponsiveness

• Improving lung function

• Lowering the risk of asthma exacerbations

• Improving long-term symptom control

Common inhaled corticosteroids include:

• Budesonide

• Fluticasone

• Beclomethasone

Because these medications treat inflammation rather than acute bronchospasm, they should be taken consistently as prescribed, even when symptoms improve.

Short-Acting Beta₂-Agonists (SABA)

A rescue inhaler containing a short-acting beta₂-agonist provides rapid relief of acute asthma symptoms.

Common options include:

• Albuterol (Ventolin)

• Albuterol (ProAir)

• Albuterol (Proventil)

Many adolescents with exercise-induced symptoms also benefit from using albuterol shortly before physical activity to reduce exercise-induced bronchoconstriction.

Managing Allergic Rhinitis to Improve Asthma Control

Allergic rhinitis and asthma frequently coexist because both involve airway inflammation. Treating allergic rhinitis often improves asthma symptom control and reduces exacerbation risk.

Treatment options include:

• Second-generation antihistamines such as cetirizine or loratadine

• Intranasal corticosteroids for persistent nasal symptoms

• Allergy testing when environmental allergens are suspected

• Allergen immunotherapy for selected patients with confirmed allergic triggers

Addressing upper airway inflammation is an important component of comprehensive asthma management.

Monitoring Treatment Response

Asthma control should be assessed regularly to determine whether treatment should be maintained, stepped up, or stepped down.

Patients are generally reassessed:

• Within 1–3 months after starting therapy

• Every 3–12 months once asthma is well controlled

• Soon after any asthma exacerbation

Healthcare providers should monitor:

• Frequency of daytime symptoms

• Nighttime awakenings

• Rescue inhaler use

• Exercise tolerance

• Peak expiratory flow or spirometry

• Asthma exacerbations

• School attendance

• Participation in sports

• Medication adherence

• Correct inhaler technique

• Medication side effects

If symptoms remain controlled for at least three months, therapy may be stepped down under medical supervision. Before intensifying treatment, clinicians should confirm adherence, inhaler technique, and trigger avoidance.

Lifestyle and Health Promotion Strategies

Asthma Self-Management Education

Teaching adolescents to manage their condition independently improves long-term outcomes.

Education should include:

• Proper inhaler technique

• Daily use of controller medication

• Appropriate rescue inhaler use

• Recognition of worsening symptoms

• Following a personalized asthma action plan

Environmental Trigger Reduction

Reducing exposure to asthma triggers helps decrease airway inflammation and symptom frequency.

Recommended measures include:

• Wash bedding weekly in hot water to reduce dust mites

• Control indoor mold and moisture

• Minimize pet dander exposure when applicable

• Reduce cockroach exposure

• Monitor pollen counts before outdoor activities

• Avoid tobacco smoke

• Limit exposure to perfumes, aerosol sprays, scented candles, and strong cleaning products

Exercise and Sports Participation

Well-controlled asthma should not prevent adolescents from participating in physical activity or competitive sports.

Patients with exercise-induced bronchoconstriction may benefit from using a rescue inhaler before exercise while continuing their prescribed controller medication.

Psychosocial Support

Adolescents may feel embarrassed about using inhalers in public or during sports. Healthcare providers should encourage open communication, reinforce medication adherence, and assess for anxiety, depression, or other psychosocial factors that may interfere with asthma management.

Key Clinical Points

Daily low-dose inhaled corticosteroids remain the preferred controller therapy for adolescents with mild persistent asthma. Rescue medication should be readily available for acute symptoms and exercise-induced bronchospasm. Long-term asthma control depends on medication adherence, correct inhaler technique, regular monitoring, treatment of allergic rhinitis, and minimizing environmental triggers.

Early intervention and individualized asthma action plans help reduce exacerbations, improve lung function, and allow adolescents to maintain normal academic, athletic, and social activities.

What Is the First-Line Treatment for Mild Persistent Asthma in Adolescents?

Current clinical guidelines recommend a daily low-dose inhaled corticosteroid (ICS) as the preferred controller medication, combined with a short-acting beta₂-agonist (SABA) for quick relief of acute symptoms and pre-exercise use when appropriate.

Why Is Allergic Rhinitis Important in Asthma?

Inflammation affecting the nose and airways is closely linked. Treating allergic rhinitis improves overall asthma control, reduces symptom frequency, and lowers the risk of asthma exacerbations.

How Often Should Asthma Be Reassessed?

Most adolescents should be evaluated within 1–3 months after starting therapy and every 3–12 months thereafter, depending on symptom control and exacerbation risk.

Can Adolescents with Asthma Play Sports?

Yes. Most adolescents with well-controlled asthma can safely participate in sports, including competitive athletics. Appropriate controller therapy and pre-exercise rescue medication help prevent exercise-induced symptoms.

What Should Patients Monitor at Home?

Patients should regularly track:

• Daytime symptoms

• Nighttime awakenings

• Rescue inhaler use

• Exercise tolerance

• Peak flow readings (if recommended)

• Exposure to known asthma triggers

• Any worsening symptoms requiring medical attention

Frequently Asked Questions

What defines mild persistent asthma?

Mild persistent asthma causes symptoms more than twice per week but not daily, with nighttime awakenings occurring several times per month and minor limitations in daily activities.

Are inhaled corticosteroids safe for adolescents?

Yes. Low-dose inhaled corticosteroids are considered the most effective long-term controller medications for persistent asthma. When used as prescribed, they have a strong safety profile and significantly reduce the risk of severe asthma attacks.

Should adolescents use their rescue inhaler every day?

No. Frequent rescue inhaler use suggests inadequate asthma control and may indicate the need to adjust controller therapy.

Can asthma symptoms improve over time?

Some adolescents experience symptom improvement as they mature, but asthma often remains a chronic condition that requires ongoing monitoring and individualized treatment.

When should asthma treatment be adjusted?

Treatment should be adjusted whenever symptoms worsen, rescue medication use increases, lung function declines, or asthma remains uncontrolled despite appropriate medication use and good adherence.

Asthma guidelines recommend daily low-dose inhaled corticosteroids as the preferred first-line controller therapy for adolescents with mild persistent asthma because they reduce airway inflammation, improve lung function, and decrease exacerbation risk.

Effective asthma management combines evidence-based medication, regular follow-up, trigger avoidance, treatment of allergic rhinitis, and patient education to achieve long-term symptom control and maintain normal physical activity.

Routine assessment of symptom frequency, rescue inhaler use, lung function, medication adherence, and inhaler technique allows clinicians to adjust therapy using a stepwise approach and optimize long-term outcomes.

References

Arcangelo, V. P., Peterson, A. M., Wilbur, V., & Reinhold, J. A. (2017). Pharmacotherapeutics for Advanced Practice: A Practical Approach (4th ed.). Wolters Kluwer.

Global Initiative for Asthma. (2024). Global Strategy for Asthma Management and Prevention. https://ginasthma.org/

National Asthma Education and Prevention Program. (2020). 2020 Focused Updates to the Asthma Management Guidelines. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health-topics/asthma

NSG 508 Week 3 Discussion

Reddel, H. K., Bacharier, L. B., Bateman, E. D., Brightling, C. E., Brusselle, G. G., Buhl, R., et al. (2022). Global Initiative for Asthma strategy 2021: Executive summary and rationale for key changes. American Journal of Respiratory and Critical Care Medicine, 205(1), 17–35. https://doi.org/10.1164/rccm.202109-2205PP